Analytical methods, compound overviews, and quality standards for peptide research — written for researchers who verify before they rely. All content concerns laboratory research use only.
August 22, 2026
Kisspeptin-10 is the minimal active fragment of the KISS1 peptide family, a standard probe in receptor research. Its two research tracks, structure, and product quality.
Read the article →August 22, 2026
Sermorelin is GHRH(1-29) — the fragment that defined GHRH-receptor research and the baseline compound its analogues are measured against. Structure, literature, product quality.
Read the article →August 22, 2026
Adamax is an adamantane-modified analogue of Semax with a thinner but growing research literature. How it differs from its parent, and what its certificate should show.
Read the article →August 22, 2026
5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. Its research background in NAD+ and methylation metabolism, and what its certificate should show.
Read the article →August 22, 2026
PT-141 (bremelanotide) is a cyclic heptapeptide studied at melanocortin receptors. Its structure, its relationship to Melanotan II, and what its certificate should show.
Read the article →August 22, 2026
CJC-1295 and Ipamorelin are distinct molecules with different receptor targets. What each is, why the pairing recurs in research, and how a blend certificate should treat them.
Read the article →August 22, 2026
KLOW is a research blend of four peptides — BPC-157, TB-500, GHK-Cu and KPV. What each component is, why blends appear in research catalogs, and how to verify a lot.
Read the article →August 20, 2026
A practical, evidence-first checklist for evaluating any research peptide supplier: per-product COAs, named laboratories, verifiable documents, and the red flags that matter.
Read the article →August 20, 2026
A research overview of MOTS-c: the 16-residue mitochondrial-derived peptide, its AMPK-focused metabolic literature, and how to verify lot purity.
Read the article →August 20, 2026
A research overview of Selank: the tuftsin-derived heptapeptide, its GABA- and BDNF-focused preclinical literature, and how to verify lot purity.
Read the article →August 20, 2026
A research overview of Semax: its heptapeptide structure, the BDNF-focused preclinical literature, and what to check on a certificate of analysis.
Read the article →August 20, 2026
A research overview of Epithalon (epitalon, AEDG): its origin in pineal peptide research, the telomerase literature, and how to verify lot purity.
Read the article →August 20, 2026
What separates CJC-1295 with DAC from the no-DAC form, how the Drug Affinity Complex changes stability, and what a quality lot looks like on paper.
Read the article →August 19, 2026
BPC-157 and TB-500 come from unrelated proteins and act through unrelated mechanisms. A side-by-side look at their origins, mechanisms, research literatures, and when a study design calls for one, the other, or both.
Read the article →August 19, 2026
Tirzepatide (LY3298176) is a 39-amino-acid peptide that activates both GIP and GLP-1 receptors. How it works, its structure, half-life, approvals and how it compares with semaglutide.
Read the article →August 19, 2026
Semaglutide is the reference GLP-1 receptor research peptide. What the acylated analog is, why the fatty-acid modification matters for handling, and how researchers verify material.
Read the article →August 19, 2026
Ipamorelin is a five-residue growth-hormone secretagogue prized in research for receptor selectivity. Structure, how it differs from GHRP-2/GHRP-6, handling, and lot verification.
Read the article →August 19, 2026
Tesamorelin is a 44-residue GHRH analog with a stabilizing N-terminal modification. What differentiates it from other GHRH-pathway peptides, plus storage behavior and quality checks.
Read the article →August 19, 2026
TB-500 is the actin-binding fragment of thymosin β4 studied in tissue-repair models. Structure, handling, how it differs from full-length Tβ4, and the quality checks that matter.
Read the article →August 19, 2026
Retatrutide (LY3437943) is an investigational peptide that activates GIP, GLP-1 and glucagon receptors. What it is, how it works, its structure, half-life, trial results and FDA status.
Read the article →Verify before you rely.
Every compound in the catalog ships with a product-specific certificate of analysis — HPLC purity, mass-spec identity.
Browse the research catalog →Get 10% off your first order
Join the Heartland list for new compounds, fresh certificates, and your welcome code by email.
One code per customer. Cannot be combined with other offers. Research use only.
